Mealey's (March 9, 2023, 1:46 PM EST) -- RICHMOND, Va. — A federal district court did not err in dismissing claims in a class action alleging that a clinical-stage biopharmaceutical company and certain of its current and former senior...
Panel Finds Drug Maker’s Statements Not To Be Materially Misleading
To view the full article, register now.
Try for FREE for fourteen days
Already a subscriber? Click here to login